515 related articles for article (PubMed ID: 35493449)
1. Research Trends and Most Influential Clinical Studies on Anti-PD1/PDL1 Immunotherapy for Cancers: A Bibliometric Analysis.
Liu Y; Xu Y; Cheng X; Lin Y; Jiang S; Yu H; Zhang Z; Lu L; Zhang X
Front Immunol; 2022; 13():862084. PubMed ID: 35493449
[TBL] [Abstract][Full Text] [Related]
2. Global research landscape and trends of lung cancer immunotherapy: A bibliometric analysis.
Liu Y; Cheng X; Han X; Cheng X; Jiang S; Lin Y; Zhang Z; Lu L; Qu B; Chen Y; Zhang X
Front Immunol; 2022; 13():1032747. PubMed ID: 36532038
[TBL] [Abstract][Full Text] [Related]
3. Research landscape and trends of melanoma immunotherapy: A bibliometric analysis.
Liu Y; Yu L; Liang Y; Cheng X; Jiang S; Yu H; Zhang Z; Lu L; Qu B; Chen Y; Zhang X
Front Oncol; 2022; 12():1024179. PubMed ID: 36698407
[TBL] [Abstract][Full Text] [Related]
4. Bibliometric Analysis of the Top-Cited Publications and Research Trends for Stereotactic Body Radiotherapy.
Liu Y; Li J; Cheng X; Zhang X
Front Oncol; 2021; 11():795568. PubMed ID: 34926312
[TBL] [Abstract][Full Text] [Related]
5. Trends in the Research Into Immune Checkpoint Blockade by Anti-PD1/PDL1 Antibodies in Cancer Immunotherapy: A Bibliometric Study.
Sun Y; Jiang L; Wen T; Guo X; Shao X; Qu H; Chen X; Song Y; Wang F; Qu X; Li Z
Front Pharmacol; 2021; 12():670900. PubMed ID: 34489691
[TBL] [Abstract][Full Text] [Related]
6. Global research landscape and trends of cancer radiotherapy plus immunotherapy: A bibliometric analysis.
Liu Y; Jiang X; Wu Y; Yu H
Heliyon; 2024 Mar; 10(5):e27103. PubMed ID: 38449655
[TBL] [Abstract][Full Text] [Related]
7. Research landscape and trends of lung cancer radiotherapy: A bibliometric analysis.
Liu Y; Jiang S; Lin Y; Yu H; Yu L; Zhang X
Front Oncol; 2022; 12():1066557. PubMed ID: 36439443
[TBL] [Abstract][Full Text] [Related]
8. [Immunotherapy in non-small cell lung cancer: inhibition of PD1/PDL1 pathway].
Guilleminault L; Carmier D; Heuzé-Vourc'h N; Diot P; Pichon E
Rev Pneumol Clin; 2015 Feb; 71(1):44-56. PubMed ID: 25687821
[TBL] [Abstract][Full Text] [Related]
9. The top 100 highly cited articles on anterior cruciate ligament from 2000 to 2019: A bibliometric and visualized analysis.
Zhu Y; Zhang C; Wang J; Xie Y; Wang L; Xu F
Orthop Traumatol Surg Res; 2021 Dec; 107(8):102988. PubMed ID: 34146752
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges.
Giroux Leprieur E; Dumenil C; Julie C; Giraud V; Dumoulin J; Labrune S; Chinet T
Eur J Cancer; 2017 Jun; 78():16-23. PubMed ID: 28407528
[TBL] [Abstract][Full Text] [Related]
11. Global research trends on the links between gut microbiota and cancer immunotherapy: A bibliometric analysis (2012-2021).
Yang S; Zhao S; Ye Y; Jia L; Lou Y
Front Immunol; 2022; 13():952546. PubMed ID: 36090978
[TBL] [Abstract][Full Text] [Related]
12. Bibliometric and visualized analysis of the top-100 highly cited articles on immunotherapy for endometrial cancer.
Zheng W; Wu Y; Wang Y; Cheng J; Shen W
Medicine (Baltimore); 2023 Jul; 102(27):e34228. PubMed ID: 37417594
[TBL] [Abstract][Full Text] [Related]
13. Bibliometric study of immunotherapy for hepatocellular carcinoma.
Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
[TBL] [Abstract][Full Text] [Related]
14. Evolutions in the management of non-small cell lung cancer: A bibliometric study from the 100 most impactful articles in the field.
Chen S; Qiao Y; Chen J; Li Y; Xie J; Cui P; Huang Z; Huang D; Gao Y; Hu Y; Liu Z
Front Oncol; 2022; 12():939838. PubMed ID: 36059661
[TBL] [Abstract][Full Text] [Related]
15. Top 100 most-cited articles on renal cell carcinoma: A bibliometric analysis.
Zhou H; Cui F; Lv D; Gong Q; Wen J; Shuang W
Medicine (Baltimore); 2023 Feb; 102(6):e32926. PubMed ID: 36820552
[TBL] [Abstract][Full Text] [Related]
16. A Bibliometric Analysis of the Top 100 Most-Cited Papers Concerning Dental Fluorosis.
Goebel MC; Rocha AO; Santos PS; Bolan M; Martins-Júnior PA; Santana CM; Cardoso M
Caries Res; 2023; 57(4):509-515. PubMed ID: 37100040
[TBL] [Abstract][Full Text] [Related]
17. A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer.
Gan Y; He Q; Li C; Alsharafi BLM; Zhou H; Long Z
Front Oncol; 2023; 13():1146515. PubMed ID: 36959803
[TBL] [Abstract][Full Text] [Related]
18. The 100 top-cited studies in cancer immunotherapy.
Zhang Y; Quan L; Du L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2282-2292. PubMed ID: 31169039
[No Abstract] [Full Text] [Related]
19. The 100 most cited papers on thymic epithelial tumours: a bibliometric analysis.
Qiu G; Wang F; Zhang H; Zheng Y; Wang Z; Wang Y
J Thorac Dis; 2020 Dec; 12(12):7402-7415. PubMed ID: 33447429
[TBL] [Abstract][Full Text] [Related]
20. An evidence mapping and scientometric analysis of the top-100 most cited clinical trials of anti-PD-1/PD-L1 drugs to treat cancers.
Liu M; Gao Y; Yuan Y; Shi S; Wu J; Tian J; Zhang J
Biomed Pharmacother; 2021 Nov; 143():112238. PubMed ID: 34649362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
